首页> 外文OA文献 >PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency

【2h】

PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency

机译：PND31对有C1-酯酶抑制剂（C1-INH）缺乏症的成年人进行遗传性血管性水肿（HAE）急性发作的对症治疗的Firazyr®（依卡替班）的模型经济评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tilden D.; Cottrell S.; Tocchini L.; Jayaram N.; Sinani R.; Barnes D.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Fast 3: a phase III randomized double-blind, placebo-controlled multicenter study of Icatibant for subcutaneous injection in patients with acute Attacks of Hereditary Angioedema (HAE) [J] . B Ritchie Allergy, Asthma & Clinical Immunology . 2010,第SUPPLEMENTa1期

机译：斋戒3：急性遗传性血管性水肿（HAE）发作患者的依卡替班皮下注射的III期随机双盲，安慰剂对照多中心研究
2. A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant [J] . M Bas, J Greve, G Kojda, Critical care : . 2006,第Suppla1期

机译：一种用于治疗遗传性血管性水肿患者的急性血管性水肿发作的新颖治疗概念：使用缓激肽-B2受体拮抗剂依卡替班，即使在严重的肿胀发作中也能获得多种成功的治疗方法
3. EVALUATING THE USE OF ICATIBANT INJECTIONS (FIRAZYR (R)) WITH C1 ESTERASE INHIBITORS (CINRYZE (R) AND BERINERT (R)) DURING PREGNANCY OF A TYPE III HEREDITARY ANGIOEDEMA PATIENT. [J] . Ansary F. F., Craig T. J. Annals of allergy, asthma, and immunology . 2014,第5Suppla1期

机译：评估在III型遗传性血管性血管病患者怀孕期间使用C1酯酶抑制剂（CINRYZE（R）和BERINERT（R））与杀伤剂注射（FIRAZYR（R））的使用。
4. Urticaria and Angioedema: 165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency [O] . Konrad Bork, Jochen Hardt 2012

机译：荨麻疹和血管性水肿：165早期与延缓治疗伊卡替班（缓激肽2受体拮抗剂）对因C1-INH缺乏而遗传性血管性水肿的患者
5. Subcutaneous (SC) vs Intravenous (IV) C1-esterase-inhibitor (C1-INH) Replacement Treatment For The Prevention Of Attacks Of Hereditary Angioedema (HAE): A Population-based Exposure-response Analysis [O] . Bruce L. Zuraw, Marco Cicardi, Timothy J. Craig, 2018

机译：皮下（SC）对静脉内（IV）C1-酯酶抑制剂（C1-INH）预防遗传性血管血肿（HAE）的攻击（HA-INH）的替代处理：基于人群的曝光响应分析

PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency

著录项

引文网络

相似文献

相关主题

期刊订阅